90 related articles for article (PubMed ID: 22426041)
1. Encapsulated cell-based biodelivery of meteorin is neuroprotective in the quinolinic acid rat model of neurodegenerative disease.
Tornøe J; Torp M; Jørgensen JR; Emerich DF; Thanos C; Bintz B; Fjord-Larsen L; Wahlberg LU
Restor Neurol Neurosci; 2012; 30(3):225-36. PubMed ID: 22426041
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral delivery of meteorin protects striatal neurons against excitotoxicity and reverses motor deficits in the quinolinic acid rat model.
Jørgensen JR; Emerich DF; Thanos C; Thompson LH; Torp M; Bintz B; Fjord-Larsen L; Johansen TE; Wahlberg LU
Neurobiol Dis; 2011 Jan; 41(1):160-8. PubMed ID: 20840868
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
4. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
[TBL] [Abstract][Full Text] [Related]
5. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
Emerich DF; Bruhn S; Chu Y; Kordower JH
Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.
Sadan O; Shemesh N; Barzilay R; Dadon-Nahum M; Blumenfeld-Katzir T; Assaf Y; Yeshurun M; Djaldetti R; Cohen Y; Melamed E; Offen D
Exp Neurol; 2012 Apr; 234(2):417-27. PubMed ID: 22285250
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral gene delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic acid-induced excitotoxicity.
Sanagi T; Yabe T; Yamada H
J Neuropathol Exp Neurol; 2010 Mar; 69(3):224-33. PubMed ID: 20142768
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage.
Menei P; Pean JM; Nerrière-Daguin V; Jollivet C; Brachet P; Benoit JP
Exp Neurol; 2000 Jan; 161(1):259-72. PubMed ID: 10683292
[TBL] [Abstract][Full Text] [Related]
10. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
[TBL] [Abstract][Full Text] [Related]
11. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
[TBL] [Abstract][Full Text] [Related]
12. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease.
Emerich DF; Lindner MD; Winn SR; Chen EY; Frydel BR; Kordower JH
J Neurosci; 1996 Aug; 16(16):5168-81. PubMed ID: 8756445
[TBL] [Abstract][Full Text] [Related]
13. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
Vazey EM; Chen K; Hughes SM; Connor B
Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease.
Giampà C; Patassini S; Borreca A; Laurenti D; Marullo F; Bernardi G; Menniti FS; Fusco FR
Neurobiol Dis; 2009 Jun; 34(3):450-6. PubMed ID: 19281846
[TBL] [Abstract][Full Text] [Related]
15. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
de Almeida LP; Zala D; Aebischer P; Déglon N
Neurobiol Dis; 2001 Jun; 8(3):433-46. PubMed ID: 11442352
[TBL] [Abstract][Full Text] [Related]
17. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
Ryu JK; Choi HB; McLarnon JG
Neuroscience; 2006 Sep; 141(4):1835-48. PubMed ID: 16809003
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum.
Emerich DF; Winn SR
Cell Transplant; 2004; 13(3):253-9. PubMed ID: 15191163
[TBL] [Abstract][Full Text] [Related]
19. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
20. Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease.
Emerich DF; Mooney DJ; Storrie H; Babu RS; Kordower JH
Neurotox Res; 2010 Jan; 17(1):66-74. PubMed ID: 19588214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
